SELLAS Life Sciences Group, Inc. Profile Avatar - Palmy Investing

SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunot…

Biotechnology
US, New York [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

SELLAS Life Sciences Group, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

SELLAS Life Sciences Group, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of SELLAS Life Sciences Group, Inc..

End of SLS's Analysis
CIK: 1390478 CUSIP: 81642T209 ISIN: US81642T2096 LEI: - UEI: -
Secondary Listings
SLS has no secondary listings inside our databases.